C. Fusciello

A specific miRNA signature correlates with complete pathological response to neoadjuvant chemoradiotherapy in locally advanced rectal cancer.

P. Ubezio, M. D’Incalci, S. Pepe, 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Resistance to anti-PD-1-based immunotherapy in basal cell carcinoma: a case report and review of the literature

G. Botti, G. Scognamiglio, S. Ferrone, 2018, Journal of Immunotherapy for Cancer.

Ipilimumab in the treatment of metastatic melanoma: management of adverse events

S. Ferrone, S. Pepe, F. Sabbatino, 2014, OncoTargets and therapy.

Melanoma and immunotherapy bridge 2015

Andrew J. Park, A. Hauschild, J. Malvehy, 2016, Journal of Translational Medicine.

The dual PI3K/mTOR inhibitor PKI-587 enhances sensitivity to cetuximab in EGFR-resistant human head and neck cancer models

R. Bianco, L. Formisano, B. Veneziani, 2014, British Journal of Cancer.

Effect of p53 activity on the sensitivity of human glioblastoma cells to PARP‐1 inhibitor in combination with topoisomerase i inhibitor or radiation

A. Leonardi, S. Ferrone, D. Somma, 2014, Cytometry. Part A : the journal of the International Society for Analytical Cytology.

Immune Checkpoint Inhibitors in Melanoma and HIV Infection

G. Botti, P. Ascierto, G. Scognamiglio, 2017, The open AIDS journal.

Melanoma and immunotherapy bridge 2015

Andrew J. Park, Ludmila V. Danilova, David C. Smith, 2016, Journal of Translational Medicine.

Translational Research in Cutaneous Melanoma: New Therapeutic Perspectives.

C. Ferrone, G. Scognamiglio, S. Ferrone, 2017, Anti-Cancer Agents in Medicinal Chemistry.